Finanzen von BiomX Inc (PHGE)PHGEBiomX Inc

In the context of the broader market, PHGE competes directly with industry leaders such as REVB and TCRT. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, PHGE's gross margin of N/A stands against REVB's N/A and TCRT's N/A. Such benchmarking helps identify whether BiomX Inc is trading at a premium or discount relative to its financial performance.

Biomx has shown no revenue generation in recent quarters, with total revenue of $332,000 in Q2 2026, while net income continues to decline, reaching a loss of $37.72 million in the same quarter. The current ratio has dropped to 1.24, indicating potential liquidity issues.